Effects of estrogen on gene expression profiles in mouse hypothalamus and white adipose tissue: target genes include glutathione peroxidase 3 and cell death-inducing DNA fragmentation factor, alpha-subunit-like effector A.

Obesity has become a major health problem in many parts of the world. Estrogens are known to reduce adipose tissue mass in both humans and animals but the molecular mechanisms are not well characterized. We used gene expression profiling to study long-term effects of estrogen on gene expression in mouse white adipose tissue and hypothalamus. Overall, the effects of estrogen on hypothalamic gene expression were much smaller than the corresponding effects on white adipose tissue gene expression. We characterize in detail estrogenic regulation of glutathione peroxidase 3 (GPX3). Our studies suggest that GPX3 is a direct estrogen receptor alpha target gene in white adipose tissue. Since obesity is correlated with oxidative stress, and GPX3 has been demonstrated to be lower in obesity and higher after weight loss, we hypothesize that GPX3 is one important mediator of effects of estrogen in relation to fat mass. Additional genes that were affected by estrogen in adipose tissue include cell death-inducing DNA fragmentation factor, alpha-subunit-like effector A (CIDEA), a gene shown to be related to body fat in mice. We conclude that estrogen has large effects on gene expression in white adipose tissue and hypothesize that GPX3 and CIDEA could be important mediators of the effects of estrogen on fat mass.

[1]  M. Brandi,et al.  Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. , 2007, Endocrinology.

[2]  P. Sismondi,et al.  Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes. , 2007, Maturitas.

[3]  D. Pfaff,et al.  Silencing of estrogen receptor α in the ventromedial nucleus of hypothalamus leads to metabolic syndrome , 2007, Proceedings of the National Academy of Sciences.

[4]  M. Brandi,et al.  Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner , 2006 .

[5]  D. Roesch.  Effects of selective estrogen receptor agonists on food intake and body weight gain in rats , 2006, Physiology & Behavior.

[6]  P. Arner,et al.  A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity. , 2005, Diabetes.

[7]  P. Arner,et al.  Changes in Adipose Tissue Gene Expression with Energy-restricted Diets in Obese Women , 2022 .

[8]  L. Gan,et al.  Regulation of global gene expression by ovariectomy and estrogen in female adipose tissue. , 2005, Obesity research.

[9]  B. Katzenellenbogen,et al.  Estrogen receptor regulation of quinone reductase in breast cancer: implications for estrogen-induced breast tumor growth and therapeutic uses of tamoxifen. , 2005, Frontiers in bioscience : a journal and virtual library.

[10]  H. Aso,et al.  Role of caveolin‐1 and cytoskeletal proteins, actin and vimentin, in adipogenesis of bovine intramuscular preadipocyte cells , 2004, Cell biology international.

[11]  P. Magistretti,et al.  Quantitative RT-PCR Analysis of Uncoupling Protein Isoforms in Mouse Brain Cortex: Methodological Optimization and Comparison of Expression with Brown Adipose Tissue and Skeletal Muscle , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  J. Loscalzo,et al.  Determinants of Human Plasma Glutathione Peroxidase (GPx-3) Expression* , 2004, Journal of Biological Chemistry.

[13]  M. Nilsson,et al.  Gene expression profiling identifies liver X receptor alpha as an estrogen-regulated gene in mouse adipose tissue. , 2004, Journal of molecular endocrinology.

[14]  Sheng-Cai Lin,et al.  Cidea-deficient mice have lean phenotype and are resistant to obesity , 2003, Nature Genetics.

[15]  J. Lovejoy.  The menopause and obesity. , 2003, Primary care.

[16]  E. Benjamin,et al.  Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[17]  K. Dahlman-Wright,et al.  Estrogen Receptor (ER)-β Reduces ERα-Regulated Gene Transcription, Supporting a “Ying Yang” Relationship between ERα and ERβ in Mice , 2003 .

[18]  M. Rendell,et al.  Effects of Estrogen Replacement Therapy on Abdominal Fat Compartments as Related to Glucose and Lipid Metabolism in Early Postmenopausal Women , 2002, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[19]  S. Olusi.  Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans , 2002, International Journal of Obesity.

[20]  K. Dahlman-Wright,et al.  Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. , 2002, The Journal of endocrinology.

[21]  H. Pijl,et al.  Protection from obesity and insulin resistance in mice overexpressing human apolipoprotein C1. , 2001, Diabetes.

[22]  E. Blaak,et al.  Gender differences in fat metabolism , 2001, Current opinion in clinical nutrition and metabolic care.

[23]  S. Safe,et al.  Differential gene expression in response to methoxychlor and estradiol through ERalpha, ERbeta, and AR in reproductive tissues of female mice. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  N. Geary.  Estradiol, CCK and satiation , 2001, Peptides.

[25]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Thomsen,et al.  Mechanisms of estrogen action. , 2001, Physiological reviews.

[27]  A. Thorburn,et al.  Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  G. Iwamoto,et al.  Increased adipose tissue in male and female estrogen receptor-α knockout mice , 2000 .

[29]  D. Pomp,et al.  Gene expression in hypothalamus and brown adipose tissue of mice divergently selected for heat loss. , 2000, Physiological genomics.

[30]  K. Korach,et al.  Estrogen receptor null mice: what have we learned and where will they lead us? , 1999, Endocrine reviews.

[31]  Y. Matsuzawa,et al.  Analysis of an expression profile of genes in the human adipose tissue. , 1997, Gene.

[32]  D. McDonnell,et al.  Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. , 1996, Molecular endocrinology.

[33]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Linder,et al.  Synthesis and Turnover of Ceruloplasmin in Rats Treated with 17β-Estradiol , 1993 .

[35]  W. Chin,et al.  Regulation of angiotensinogen gene expression by estrogen , 1992, Journal of hypertension.

[36]  T. Rushmore,et al.  The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. , 1991, The Journal of biological chemistry.

[37]  G. Wade,et al.  Gonadal effects on food intake and adiposity: A metabolic hypothesis , 1979, Physiology & Behavior.

[38]  E. Roy,et al.  Role of food intake in estradiol-induced body weight changes in female rats , 1977, Hormones and Behavior.

[39]  T. Emery,et al.  Peptides , 1964, Peptides.

[40]  Ton Feuth,et al.  Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes , 2005, Laboratory Investigation.

[41]  S. Souza,et al.  Estrogen Regulation of Adiposity and Fuel Partitioning EVIDENCE OF GENOMIC AND NON-GENOMIC REGULATION OF LIPOGENIC AND OXIDATIVE PATHWAYS * , 2005 .

[42]  D. Pfaff,et al.  Estrogen increases locomotor activity in mice through estrogen receptor alpha: specificity for the type of activity. , 2003, Endocrinology.

[43]  J. Gustafsson,et al.  Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. , 2000, Biochemical and biophysical research communications.

[44]  G. Iwamoto,et al.  Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[45]  L. Khaodhiar,et al.  Obesity and its comorbid conditions. , 1999, Clinical cornerstone.

[46]  J. Gustafsson,et al.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. , 1997, Science.

[47]  M. Linder,et al.  Synthesis and turnover of ceruloplasmin in rats treated with 17 beta-estradiol. , 1993, Archives of biochemistry and biophysics.

[48]  L'abbe Mr,et al.  Glutathione peroxidase activity in a healthy Canadian population. Effects of age, smoking and drinking habits, exercise and oral contraceptive use. , 1992 .

[49]  M. L’Abbé,et al.  Glutathione peroxidase activity in a healthy Canadian population. Effects of age, smoking and drinking habits, exercise and oral contraceptive use. , 1992, Trace elements in medicine.